Tom Hardys Reported Exit From Mobland May Affect Paramount Series Production
Shah Metacorp Penny Stock Retraces After Approaching 52Week High
Bandus Blockbusters Engages Investors with Weekly Stock Picking Challenge
Middle East Conflict and Rising Energy Costs Challenge Gulf Regions AI Data Center Ambitions
Microsoft Signals Potential 190 Billion Capital Spending by 2026 Amid Rising Memory Costs
HPCL Options Strategy Long Strangle Position Suggests ShortTerm Volatility Expectations
UGI Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher
STRZ Q1 2026 Earnings Massive EPS Miss Sends Mixed Signals as Stock Rises
GoPro Q1 2026 Earnings Deep EPS Miss Raises Concerns Amid Modest Stock Gains
C3ai Q1 2026 Earnings WiderThanExpected Loss and Tepid Market Reception
LNKB Q4 2025 Earnings EPS Misses Estimates Amid Challenging Rate Environment
ORLY Q1 2026 Earnings EPS Surpasses Estimates Shares Slip
MACOM Technology Solutions MTSI Edges Higher Amid Semiconductor Sector Momentum
Shopify SHOP Edges Higher Testing Key Resistance at 11055
Caterpillar Inc CAT Slips 147 as Industrial Demand Concerns Weigh on Shares
Travelzoo TZOO Edges Higher as Travel Demand Stabilizes Testing Key Resistance
Rentokil Initial RTO Edges Higher as It Tests Key Resistance Levels
Eli Lillys Retatrutide Shows Strong Phase 3 Data Adding WeightLoss Pipeline Momentum
Alexanders Inc ALX Q1 2026 Earnings Solid EPS Performance Amid Market Uncertainty
Rocket Companies RKT Edges Higher Amid Cautious Trading Approaching Key Resistance
HSAI Q1 2026 Earnings EPS Surpasses Estimates by 16 Amid Revenue Uncertainty
MGIC Investment Corporation MTG Q1 2026 Earnings Slim EPS Beat as Stock Reacts Modestly
UBFO Q4 2025 Earnings Modest Earnings in a Quiet Quarter
AKTS Q1 2026 Earnings EPS Miss as PreRevenue Biotech Advances Pipeline
Cathay General Bancorp CATY Q1 2026 Earnings Strong EPS Surprise of 2275 Drives Profit Beat Despite Stock Dip
MITN Q1 2026 Earnings EPS Beats Estimates Amid Stable Portfolio Performance
Processa Pharmaceuticals Inc PCSA Q4 2025 Earnings WiderThanExpected Loss as Clinical Pipeline Progresses